Mayra E Guerrero, Vinayak N Bapat, Paul Mahoney, Amar Krishnaswamy, Mackram F Eleid, Marvin H Eng, Pradeep Yadav, Megan Coylewright, Raj Makkar, Molly Szerlip, Tamim Nazif, Susheel Kodali, Isaac George, Adam Greenbaum, Vasilis Babaliaros, Samir Kapadia, Charanjit S Rihal, Brian Whisenant, Vinod H Thourani, James M McCabe
BACKGROUND: Adequate valve performance after surgical mitral valve repair with an annuloplasty ring is not always sustained over time. The risk of repeat mitral valve surgery may be high in these patients. Transcatheter mitral valve-in-ring (MViR) is emerging as an alternative for high-risk patients. OBJECTIVES: The authors sought to assess contemporary outcomes of MViR using third-generation balloon-expandable aortic transcatheter heart valves. METHODS: Patients who underwent MViR and were enrolled in the STDS/ACC TVT (Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy) Registry between August 2015 and December 2022 were analyzed...
April 8, 2024: JACC. Cardiovascular Interventions